Founded in 2017, Preclinic Medtech (Shanghai ) Co., Ltd. was established by medical experts and engineers with abundant experience in theory and practice of combination of medicine and engineering. It is a high-tech enterprise specialized in the design, development and manufacture of high-simulation models, surgery training simulators and other devices.
In adherence to the concept of technical innovation and customer service, the company is dedicated to providing professional simulated medical products for medical professionals’ R&D tests, scheme demonstration and skill training, so as to accelerate continuous innovations in the medical industry, and make its contributions to improving the medical level and reducing suffering of patients.
Vision:
Become an excellent medical simulation solution creator.
Core value:
— Integrity and love
— Care about employees
— Quality first
— Create value for customers
— Innovative practice
Mission:
Help medical professionals in innovative practice and ability enhancement with advanced medical simulation products, enabling them to cope with serious clinical challenges calmly.
Origin:
Under the leadership of Professor Wang Chengtao of Shanghai Jiaotong University, the founding team of the company carried out research and development of medical high simulation models and virtual reality technology related products in the way of combination of medicine and industry, and completed many classic cases in the industry.
Technology development stage:
Start to explore and develop the clinical application of medical 3D printing technology.
Formal establishment:
Preclinic was founded and officially began to provide high simulation model design and manufacturing service.
Exploration of service mode:
Determine the design and development services of minimally invasive interventional surgery models and devices as the main direction of the company, and successfully develop cardiovascular model products.
Continuous improvement of products:
The cardiovascular model of Preclinic has obtained a large number of purchase orders, and the financial balance has been achieved. At the same time, the endoscopic model has been successfully developed.
Business expansion:
The company's long-term cooperation and stable number of customers exceeded 100, the sales of cardiovascular and endoscopic models increased rapidly, and the company achieved profits.
Plant expansion:
The number of members of the company has increased from about 5 in 2017 to about 50 now. The functional departments and organizational structure of the company have been gradually improved, the site has been relocated, and the plant area has reached 3000 square meters.
English 
中文 
